Tumambiling, Aisa A.
HRN: 27-00-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/06/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/06/2025
11/12/2025
IVT
500 Mg
Q8H
Acute Cholecystitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes